Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
nasal inhaler
|
| gptkbp:abusedFor |
stimulant effects
|
| gptkbp:activeIngredient |
amphetamine
|
| gptkbp:becameControlledSubstance |
1971
|
| gptkbp:containsIsomer |
racemic amphetamine
|
| gptkbp:form |
inhaler
|
| https://www.w3.org/2000/01/rdf-schema#label |
Benzedrine Inhaler
|
| gptkbp:introducedIn |
1933
|
| gptkbp:knownFor |
first commercial amphetamine product
|
| gptkbp:manufacturer |
gptkb:Smith,_Kline_&_French
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:replacedBy |
propylhexedrine inhalers
|
| gptkbp:usedFor |
nasal congestion
|
| gptkbp:withdrawn |
late 1950s
|
| gptkbp:bfsParent |
gptkb:Benzedrine
|
| gptkbp:bfsLayer |
7
|